Vikram R. Juneja

In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target

Robert T. Manguso, Hans W. Pope, Margaret D. Zimmer et al. · Nature · 2017 · 1.1K citations · Full text

Identifies Ptpn2, Vivo Crispr, Immunology +8

PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity

Vikram R. Juneja, Kathleen A. McGuire, Robert T. Manguso et al. · The Journal of Experimental Medicine · 2017 · 855 citations · Full text

Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity

Alison E. Ringel, Jefte M. Drijvers, Gregory J. Baker et al. · Cell · 2020 · 712 citations · Full text

Obesity, Cancer Immunosurveillance, Immunology +8

Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth

Sonja Kleffel, Christian Posch, Steven R. Barthel et al. · Cell · 2015 · 633 citations · Full text

Cancer Immunosurveillance, Melanoma, Medicine +3

Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade

Zachary A. Cooper, Vikram R. Juneja, Peter T. Sage et al. · Cancer Immunology Research · 2014 · 255 citations · Full text

Immunology, Immune Regulation, Immunoediting +24